Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report - Quiz - MDSpire

Depigmentation resembling vitiligo after neoadjuvant chemotherapy and pembrolizumab in early-stage triple-negative breast cancer: a case study

  • By

  • Yinglei Deng

  • Dahua Mao

  • Shaogang Zhang

  • Jing Wang

  • July 20, 2026

Share

Original Source(s)

Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report

  • by Yinglei Deng, Dahua Mao, Shaogang Zhang, Jing Wang

  • July 20, 2026

Related Content

Multimodal breast cancer diagnosis using feature fusion and deep learning

Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis

STMN1 expression is associated with chemotherapy and immunotherapy efficacy in biliary tract cancer